Transcription elongation regulator 1
Homo sapiens
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein monomer Monomer Protein × 1 PDB declaration: monomeric(1) Consistent with protein copy count | Chain A; UniProt 661–845 | Fragment:FF domains: UNP residues 661-845 Non-standard monomer:Yes (specific site not provided by mmCIF) | No other associated polymer | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;50mM Bis-Tris pH 6.5, 50 mM Ammonium sulfate, 30% Pentaerythritol ethoxylate, VAPOR DIFFUSION, HANGING DROP, temperature 277K | Resolution 2.70 Å R-free 0.283 |
| 2 | Protein monomer Monomer Protein × 1 PDB declaration: monomeric(1) Consistent with protein copy count | Chain B; UniProt 661–845 | Fragment:FF domains: UNP residues 661-845 Non-standard monomer:Yes (specific site not provided by mmCIF) | No other associated polymer | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;50mM Bis-Tris pH 6.5, 50 mM Ammonium sulfate, 30% Pentaerythritol ethoxylate, VAPOR DIFFUSION, HANGING DROP, temperature 277K | Resolution 2.70 Å R-free 0.283 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 3HFH | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 2DK7 Solution structure of WW domain in transcription elongation regulator 1 Deposited 2006-04-06 | Different construct Different mutation/modification Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
520–579(60 aa)
Fragment:WW domain
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 7;298 K;Ionic strength (raw mmCIF value) 120mM;Pressure ambient
NMR sample composition
0.8mM U-15N, 13C; 20mM phosphate buffer NA; 100mM NaCl; 1mM d-DTT; 0.02% NaN3; 90%H2O,10%D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 2DOD Solution structure of the first FF domain of human transcription factor CA150 Deposited 2006-04-28 | Different construct Different mutation/modification Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
651–719(69 aa)
Fragment:FF domain
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 7;298 K;Ionic strength (raw mmCIF value) 120mM;Pressure ambient
NMR sample composition
1.2mM 13C/15N-PROTEIN; 20mM d-Tris-HCl(pH7.0); 100mM NaCl; 1mM d-DTT; 0.02% NaN3; 90% H2O, 10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 2DOE Solution structure of the third FF domain of human transcription factor CA150 Deposited 2006-04-28 | Different construct Different mutation/modification Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
784–853(70 aa)
Fragment:FF domain
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 7;298 K;Ionic strength (raw mmCIF value) 120mM;Pressure ambient
NMR sample composition
1.1mM 13C/15N-PROTEIN; 20mM d-Tris-HCl(pH7.0); 100mM NaCl; 1mM d-DTT; 0.02% NaN3;90% H2O, 10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 2DOF Solution structure of the fourth FF domain of human transcription factor CA150 Deposited 2006-04-28 | Different construct Different mutation/modification Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
888–959(72 aa)
Fragment:FF domain
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 7;298 K;Ionic strength (raw mmCIF value) 120mM;Pressure ambient
NMR sample composition
1.1mM 13C/15N-PROTEIN, 20mM d-Tris-HCl(pH7.0), 100mM NaCl, 1mM d-DTT, 0.02% NaN3, 10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 2E71 Solution structure of the second FF domain of human transcription factor CA150 Deposited 2007-01-05 | Different construct Different mutation/modification Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
717–786(70 aa)
Fragment:FF domain
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 7;298 K;Ionic strength (raw mmCIF value) 120mM;Pressure ambient
NMR sample composition
20mM d-Tris-HCl(pH7.0); 100mM NaCl; 1mM d-DTT; 0.02% NaN3; 90% H2O, 10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 2KIQ Solution structure of the FF Domain 2 of human transcription elongation factor CA150 Deposited 2009-05-07 | Different construct Different mutation/modification Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
724–782(59 aa)
Fragment:UNP residues 724-782
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 7;303 K;Ionic strength (raw mmCIF value) 25;Pressure ambient
NMR sample composition
1 mM [U-100% 15N] CA150 FF2-1, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
1 mM [U-100% 13C; U-100% 15N] CA150 FF2-2, 100% D2O | 100% D2O
|
Resolution not provided |
| 2KIS Solution structure of CA150 FF1 domain and FF1-FF2 interdomain linker Deposited 2009-05-08 | Different construct Different mutation/modification Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
659–724(66 aa)
Fragment:FF1 domain: UNP residues 659-724
|
Not recorded | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 6.5;285 K;Ionic strength (raw mmCIF value) 0.137;Pressure ambient
NMR sample composition
1-1.7 mM [U-99% 13C; U-99% 15N] protein, 95% H2O/5% D2O | 95% H2O/5% D2O
|
Resolution not provided |
| 2MW9 NMR structure of FBP28 WW2 Y438R mutant Deposited 2014-11-03 | Different construct Different mutation/modification Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
428–464(37 aa)
Fragment:WW 2 domain residues 428-464
|
Mutation:Y438R | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 6.5;285 K;Pressure ambient
NMR sample composition
0.7 mM protein, 100 mM sodium chloride, 20 mM sodium phosphate, 1 mM sodium azide, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 2MWA NMR structure of FBP28 WW2 mutant Y446L Deposited 2014-11-03 | Different construct Different mutation/modification Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
428–464(37 aa)
Fragment:WW 2 domain residues 430-466
|
Mutation:Y446L | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 6.5;285 K;Pressure ambient
NMR sample composition
0.7 mM protein, 100 mM sodium chloride, 20 mM sodium phosphate, 1 mM sodium azide, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 2MWB FBP28 WW2 mutant W457F Deposited 2014-11-03 | Different construct Different mutation/modification Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
428–464(37 aa)
Fragment:WW 2 domain residues 430-466
|
Mutation:W457F | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 6.5;285 K;Pressure ambient
NMR sample composition
0.7 mM protein, 100 mM sodium chloride, 20 mM sodium phosphate, 1 mM sodium azide, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 2MWD NMR structure of FBP28 WW2 mutant Y438R DNDC Deposited 2014-11-04 | Different construct Different mutation/modification Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
433–460(28 aa)
Fragment:WW 2 domain residues 433-460
|
Mutation:Y438R | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 6.5;285 K;Pressure ambient
NMR sample composition
0.7 mM protein, 100 mM sodium chloride, 20 mM sodium phosphate, 1 mM sodium azide, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 2MWE NMR structure of FBP28 WW2 mutant Y438R, L453A DNDC Deposited 2014-11-04 | Different construct Different mutation/modification Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
433–460(28 aa)
Fragment:WW 2 domain residues 433-460
|
Mutation:Y238R, L453A | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 6.5;285 K;Pressure ambient
NMR sample composition
0.7 mM protein, 100 mM sodium chloride, 20 mM sodium phosphate, 1 mM sodium azide, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 2MWF NMR structure of FBP28 WW2 mutant Y438R DN Deposited 2014-11-04 | Different construct Different mutation/modification Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
433–464(32 aa)
Fragment:WW 2 domain residues 433-464
|
Mutation:Y438R | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 6.5;285 K;Pressure ambient
NMR sample composition
0.7 mM protein, 100 mM sodium chloride, 20 mM sodium phosphate, 1 mM sodium azide, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 2N4R NMR structure of Fbp28 WW domain L453D mutant Deposited 2015-07-01 | Different construct Different mutation/modification Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
428–464(37 aa)
|
Mutation:L453D | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 5.8;285 K;Pressure ambient
NMR sample composition
500-1000 uM protein, 25 mM sodium phosphate, 100 mM sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 2N4S NMR structure of Fbp28 WW domain L453E mutant Deposited 2015-07-01 | Different construct Different mutation/modification Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
428–464(37 aa)
|
Mutation:L453E | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 5.8;285 K;Pressure ambient
NMR sample composition
500-1000 uM protein, 25 mM sodium phosphate, 100 mM sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 2N4T NMR structure of Fbp28 WW domain L453W mutant Deposited 2015-07-01 | Different construct Different mutation/modification Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
428–464(37 aa)
|
Mutation:L453W | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 5.8;285 K;Pressure ambient
NMR sample composition
500-1000 uM protein, 25 mM sodium phosphate, 100 mM sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 2N4U NMR structure of Fbp28 WW domain E454Y mutant Deposited 2015-07-01 | Different construct Different mutation/modification Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
428–464(37 aa)
|
Mutation:E454Y | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 5.8;285 K;Pressure ambient
NMR sample composition
500-1000 uM protein, 25 mM sodium phosphate, 100 mM sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 2N4V NMR structure of Fbp28 WW domain T456D mutant Deposited 2015-07-01 | Different construct Different mutation/modification Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
428–464(37 aa)
|
Mutation:T456D | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 5.8;285 K;Pressure ambient
NMR sample composition
500-1000 uM protein, 25 mM sodium phosphate, 100 mM sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 2N4W NMR structure of Fbp28 WW domain T456Y mutant Deposited 2015-07-01 | Different construct Different mutation/modification Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
428–464(37 aa)
|
Mutation:T456Y | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 5.8;285 K;Pressure ambient
NMR sample composition
500-1000 uM protein, 25 mM sodium phosphate, 100 mM sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 2NNT General structural motifs of amyloid protofilaments Deposited 2006-10-24 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
428–464(37 aa)
Fragment:second WW domain
Chain B
428–464(37 aa)
Fragment:second WW domain
Chain C
428–464(37 aa)
Fragment:second WW domain
Chain D
428–464(37 aa)
Fragment:second WW domain
|
Mutation:Y446F Mutation:Y446F Mutation:Y446F Mutation:Y446F | No recorded non-water small molecule |
SOLID-STATE NMR
NMR measurement conditions
pH 7;285 K;Pressure 1
NMR sample composition
uniform 13C,15N labeling, 15 mg fibre in phosphate buffer | phosphate buffer
NMR sample composition
uniform 2H,13C,15N labeling, 15 mg fibre in phosphate buffer | phosphate buffer
NMR sample composition
uniform 15N labeling, 13C labeling is based on 1,3[13C]-glycerol as carbon source for the bacteria, 15 mg fibre in phosphate buffer | phosphate buffer
NMR sample composition
uniform 15N labeling, 13C labeling is based on 2[13C]-glycerol as carbon source for the bacteria, 15 mg fibre in phosphate buffer | phosphate buffer
|
Resolution not provided |
| 3Q1I Polo-like kinase I Polo-box domain in complex with FMPPPMSpSM phosphopeptide from TCERG1 Deposited 2010-12-17 | Different construct Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain E
99–107(9 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | 1PE PENTAETHYLENE GLYCOL × 1 PEG DI(HYDROXYETHYL)ETHER × 1 PG0 2-(2-METHOXYETHOXY)ETHANOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;30% PEG400, 0.1M MES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 1.40 Å R-free 0.222 |
| 4FQG Crystal structure of the TCERG1 FF4-6 tandem repeat domain Deposited 2012-06-25 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
895–1081(187 aa)
Fragment:TCERG1 FF4-6 tandem repeat domain (unp residues 895:1081)
|
Not recorded | NI NICKEL (II) ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 9;277 K;0.016 M NiCl2, 0.1 M Tris-HCl, 16% polyethylene glycol monomethyl ether 2000, and 0.13 M glycine, pH 9, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.00 Å R-free 0.241 |
| 4FQG Crystal structure of the TCERG1 FF4-6 tandem repeat domain Deposited 2012-06-25 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
895–1081(187 aa)
Fragment:TCERG1 FF4-6 tandem repeat domain (unp residues 895:1081)
|
Not recorded | NI NICKEL (II) ION × 1 CL CHLORIDE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 9;277 K;0.016 M NiCl2, 0.1 M Tris-HCl, 16% polyethylene glycol monomethyl ether 2000, and 0.13 M glycine, pH 9, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.00 Å R-free 0.241 |
| 7ABF Human pre-Bact-1 spliceosome core structure Deposited 2020-09-07 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein–RNA Heteromer;Protein × 12 PDB declaration: pentadecameric |
Chain A4
1–1077(1077 aa)
|
Not recorded | IHP INOSITOL HEXAKISPHOSPHATE × 1 GTP GUANOSINE-5'-TRIPHOSPHATE × 1 MG MAGNESIUM ION × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.9
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.90 Å |
| 7ABG Human pre-Bact-1 spliceosome Deposited 2020-09-07 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein–RNA Heteromer;Protein × 54 PDB declaration: 58-meric |
Chain A4
1–1098(1098 aa)
|
Not recorded | IHP INOSITOL HEXAKISPHOSPHATE × 1 GTP GUANOSINE-5'-TRIPHOSPHATE × 1 MG MAGNESIUM ION × 1 GTG 7-METHYL-GUANOSINE-5'-TRIPHOSPHATE-5'-GUANOSINE × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.9
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 7.80 Å |
| 8Q7N cryo-EM structure of the human spliceosomal B complex protomer (tri-snRNP core region) Deposited 2023-08-16 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein–RNA Heteromer;Protein × 17 PDB declaration: 21-meric |
Chain T
1–1098(1098 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.9
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.10 Å |
| 8QO9 Cryo-EM structure of a human spliceosomal B complex protomer Deposited 2023-09-28 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein–RNA Heteromer;Protein × 66 PDB declaration: 71-meric |
Chain T
1–1098(1098 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.9
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 5.29 Å |
| 9R3D Cryo-EM structure of the human pre-Bact-OTS complex (whole map) Deposited 2025-05-04 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein–RNA Heteromer;Protein × 14 PDB declaration: 17-meric |
Chain T
1–1098(1098 aa)
|
Not recorded | IHP INOSITOL HEXAKISPHOSPHATE × 1 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.9
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.12 Å |
| 9R8V Cryo-EM structure of the human pre-Bact-OTS complex (whole map) Deposited 2025-05-17 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein–RNA Heteromer;Protein × 59 PDB declaration: 63-meric |
Chain T
1–1098(1098 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.9
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 8.50 Å |
28 other PDB entries and 29 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | TCRG1_HUMAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 6–190; UniProt 661–845 Author chain B; PDBConstruct 6–190; UniProt 661–845 |